NCT02553135View on ClinicalTrials.gov

Choroideremia Gene Therapy Clinical Trial

PHASE2CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

February 28, 2018

Study Completion Date

February 28, 2018

Conditions
Choroideremia
Interventions
BIOLOGICAL

Injection of AAV2-REP1 (10e11 vg)

Single Group: single arm study

Trial Locations (1)

33136

Bascom Palmer Eye Institute, University of Miami, Miami

All Listed Sponsors
lead

Byron Lam

OTHER

NCT02553135 - Choroideremia Gene Therapy Clinical Trial | Biotech Hunter | Biotech Hunter